Nasdaq-listed MEI Pharma launches $100M Litecoin treasury plan, stock rockets 50%

MEI Pharma, a company listed on Nasdaq, just announced a bold $100 million plan to add Litecoin to its treasury reserves—and investors are loving it. The company’s stock shot up 50% on the news, signaling strong market approval. This move isn’t just a win for MEI; it’s another sign that big players are warming up to crypto, with Litecoin getting a serious credibility boost.

Editor’s Note: When a publicly traded company like MEI Pharma bets big on Litecoin, it’s not just a quirky experiment—it’s a signal that institutional confidence in crypto is growing. This could encourage other firms to follow suit, potentially driving more mainstream adoption of Litecoin and other digital assets. For crypto skeptics, moves like this might start changing the narrative from "risky speculation" to "legitimate strategy."

Ethereum just smashed through a key resistance level—the 50-day moving average—and now traders are eyeing a potential surge toward $4,000. This isn’t just a blip; it’s a signal that bullish energy is back in the crypto market, with ETH leading the charge.

Editor’s Note: For crypto watchers, breaking through technical barriers like the 50-day moving average often signals bigger moves ahead. If Ethereum holds this momentum, it could mean renewed confidence in the market and maybe even a domino effect for other altcoins. Keep an eye on that $4,000 mark—it’s the next big test.

A former SEC official, Marc Fagel, has disclosed that Ripple has already paid a hefty $125 million fine to the SEC in cash as part of its settlement in the long-running XRP lawsuit. This move signals Ripple’s effort to close the chapter on legal troubles and shift focus toward growing its business.

Editor’s Note: This isn’t just about Ripple writing a big check—it’s a sign that the company is trying to move past regulatory headaches and get back to business. For the crypto world, it’s another reminder of how costly tangling with regulators can be, but also how settlements might clear the way for companies to operate with fewer legal clouds hanging overhead. If you’re into crypto, this is a step toward stability, even if it comes at a steep price.

Two companies, Metaplanet and Semler Scientific, are locked in a high-stakes competition to amass the largest corporate Bitcoin holdings by 2025. Instead of traditional investments, they’re betting big on crypto, turning their balance sheets into a Bitcoin arms race.

Editor’s Note: This isn’t just about two firms buying Bitcoin—it’s a sign of how corporations are increasingly treating crypto as a core asset. If more companies follow suit, it could further legitimize Bitcoin as a mainstream investment, potentially influencing its price and adoption. But it also raises questions: Are they hedging against economic uncertainty, or just chasing hype? Either way, it’s a bold move that could reshape corporate finance trends.

VeChain's VET token is on the rise thanks to a combo of factors—its new StarGate staking feature is gaining serious traction, and the crypto got a visibility boost from being included in Revolut’s Learn & Earn program. With altcoins bouncing back, VET’s recent momentum has pushed it into the top 100 cryptocurrencies.

Editor’s Note: For crypto watchers, this is a sign that VeChain’s ecosystem is gaining real-world utility and broader adoption. Staking features and partnerships with platforms like Revolut can drive both price action and long-term credibility—key for investors eyeing altcoins beyond just Bitcoin and Ethereum.